ArticleCancer medicine2026

A Disproportionality Analysis of Immune Checkpoint Inhibitors in Combination With Platinum-Based Agents Using the FDA Adverse Event Reporting System Database.

Boyi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.